Cargando…

Emergence of optrA-Mediated Linezolid Resistance in Enterococcus faecium: A Molecular Investigation in a Tertiary Hospital of Southwest China from 2014–2018

PURPOSE: To investigate the potential mechanism and molecular characteristics of linezolid-non-sensitive Enterococcus faecium from a tertiary hospital in southwest China and characterize the relevant plasmids. PATIENTS AND METHODS: Linezolid-non-sensitive Enterococcus faecium (LNSEFM) isolates colle...

Descripción completa

Detalles Bibliográficos
Autores principales: Yi, Miao, Zou, Jiaqi, Zhao, Jinxin, Tang, Yu, Yuan, Yaling, Yang, Bingxue, Huang, Jinzhu, Xia, Peiwen, Xia, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742577/
https://www.ncbi.nlm.nih.gov/pubmed/35018102
http://dx.doi.org/10.2147/IDR.S339761
_version_ 1784629746382929920
author Yi, Miao
Zou, Jiaqi
Zhao, Jinxin
Tang, Yu
Yuan, Yaling
Yang, Bingxue
Huang, Jinzhu
Xia, Peiwen
Xia, Yun
author_facet Yi, Miao
Zou, Jiaqi
Zhao, Jinxin
Tang, Yu
Yuan, Yaling
Yang, Bingxue
Huang, Jinzhu
Xia, Peiwen
Xia, Yun
author_sort Yi, Miao
collection PubMed
description PURPOSE: To investigate the potential mechanism and molecular characteristics of linezolid-non-sensitive Enterococcus faecium from a tertiary hospital in southwest China and characterize the relevant plasmids. PATIENTS AND METHODS: Linezolid-non-sensitive Enterococcus faecium (LNSEFM) isolates collected from January 2014 to December 2018 were screened for resistant genes 23s rRNA, rplC, rplD, rplV, optrA, cfr, poxtA, by PCR. Molecular epidemiological analysis was performed by multilocus sequence typing (MLST). The optrA-and-poxtA co-harboring strain EFM_7150 was subjected to the whole genome sequencing (WGS) by Illumina HiSeq and Oxford Nanopore MinION. RESULTS: A total of 15 LNSEFM with linezolid MICs ranging from 4 to 16 mg/L were identified. About 66.7% (10/15) of isolates were linezolid-resistant. About 46.7% (7/15) of strains were positive for optrA. Two types of optrA variants (P and EYDNDM) were identified. About 13.3% (2/15) of isolates had poxtA. 1 harbored a L22 protein alteration (Ser77Thr). One isolate coharbored optrA (EYDNDM variant) and poxtA. There was no mutation in the gene that encoded the ribosomal protein L3/L4 or the domain V of 23S rRNA. No cfr gene was detected. Based on WGS data, optrA was associated with Tn558 inserted to radC gene and poxtA was flanked by IS1216E. CONCLUSION: OptrA is primary mechanism in linezolid-resistant Enterococcus faecium. This is the first report ofoptrA variants P and EYDNDM identified in Enterococcus faecium and optrA-and-poxtA co-harboring Enterococcus faecium clinically in southwest China. Besides, Tn558 and IS1216Es may play an important role in the dissemination of optrA and poxtA, respectively. The findings revealed the potential threat to nosocomial infection by optrA and coexistence of optrA and poxtA in Enterococcus faecium. Thus, clinical surveillance of linezolid-resistant Enterococcus is urgently needed.
format Online
Article
Text
id pubmed-8742577
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-87425772022-01-10 Emergence of optrA-Mediated Linezolid Resistance in Enterococcus faecium: A Molecular Investigation in a Tertiary Hospital of Southwest China from 2014–2018 Yi, Miao Zou, Jiaqi Zhao, Jinxin Tang, Yu Yuan, Yaling Yang, Bingxue Huang, Jinzhu Xia, Peiwen Xia, Yun Infect Drug Resist Original Research PURPOSE: To investigate the potential mechanism and molecular characteristics of linezolid-non-sensitive Enterococcus faecium from a tertiary hospital in southwest China and characterize the relevant plasmids. PATIENTS AND METHODS: Linezolid-non-sensitive Enterococcus faecium (LNSEFM) isolates collected from January 2014 to December 2018 were screened for resistant genes 23s rRNA, rplC, rplD, rplV, optrA, cfr, poxtA, by PCR. Molecular epidemiological analysis was performed by multilocus sequence typing (MLST). The optrA-and-poxtA co-harboring strain EFM_7150 was subjected to the whole genome sequencing (WGS) by Illumina HiSeq and Oxford Nanopore MinION. RESULTS: A total of 15 LNSEFM with linezolid MICs ranging from 4 to 16 mg/L were identified. About 66.7% (10/15) of isolates were linezolid-resistant. About 46.7% (7/15) of strains were positive for optrA. Two types of optrA variants (P and EYDNDM) were identified. About 13.3% (2/15) of isolates had poxtA. 1 harbored a L22 protein alteration (Ser77Thr). One isolate coharbored optrA (EYDNDM variant) and poxtA. There was no mutation in the gene that encoded the ribosomal protein L3/L4 or the domain V of 23S rRNA. No cfr gene was detected. Based on WGS data, optrA was associated with Tn558 inserted to radC gene and poxtA was flanked by IS1216E. CONCLUSION: OptrA is primary mechanism in linezolid-resistant Enterococcus faecium. This is the first report ofoptrA variants P and EYDNDM identified in Enterococcus faecium and optrA-and-poxtA co-harboring Enterococcus faecium clinically in southwest China. Besides, Tn558 and IS1216Es may play an important role in the dissemination of optrA and poxtA, respectively. The findings revealed the potential threat to nosocomial infection by optrA and coexistence of optrA and poxtA in Enterococcus faecium. Thus, clinical surveillance of linezolid-resistant Enterococcus is urgently needed. Dove 2022-01-04 /pmc/articles/PMC8742577/ /pubmed/35018102 http://dx.doi.org/10.2147/IDR.S339761 Text en © 2022 Yi et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Yi, Miao
Zou, Jiaqi
Zhao, Jinxin
Tang, Yu
Yuan, Yaling
Yang, Bingxue
Huang, Jinzhu
Xia, Peiwen
Xia, Yun
Emergence of optrA-Mediated Linezolid Resistance in Enterococcus faecium: A Molecular Investigation in a Tertiary Hospital of Southwest China from 2014–2018
title Emergence of optrA-Mediated Linezolid Resistance in Enterococcus faecium: A Molecular Investigation in a Tertiary Hospital of Southwest China from 2014–2018
title_full Emergence of optrA-Mediated Linezolid Resistance in Enterococcus faecium: A Molecular Investigation in a Tertiary Hospital of Southwest China from 2014–2018
title_fullStr Emergence of optrA-Mediated Linezolid Resistance in Enterococcus faecium: A Molecular Investigation in a Tertiary Hospital of Southwest China from 2014–2018
title_full_unstemmed Emergence of optrA-Mediated Linezolid Resistance in Enterococcus faecium: A Molecular Investigation in a Tertiary Hospital of Southwest China from 2014–2018
title_short Emergence of optrA-Mediated Linezolid Resistance in Enterococcus faecium: A Molecular Investigation in a Tertiary Hospital of Southwest China from 2014–2018
title_sort emergence of optra-mediated linezolid resistance in enterococcus faecium: a molecular investigation in a tertiary hospital of southwest china from 2014–2018
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742577/
https://www.ncbi.nlm.nih.gov/pubmed/35018102
http://dx.doi.org/10.2147/IDR.S339761
work_keys_str_mv AT yimiao emergenceofoptramediatedlinezolidresistanceinenterococcusfaeciumamolecularinvestigationinatertiaryhospitalofsouthwestchinafrom20142018
AT zoujiaqi emergenceofoptramediatedlinezolidresistanceinenterococcusfaeciumamolecularinvestigationinatertiaryhospitalofsouthwestchinafrom20142018
AT zhaojinxin emergenceofoptramediatedlinezolidresistanceinenterococcusfaeciumamolecularinvestigationinatertiaryhospitalofsouthwestchinafrom20142018
AT tangyu emergenceofoptramediatedlinezolidresistanceinenterococcusfaeciumamolecularinvestigationinatertiaryhospitalofsouthwestchinafrom20142018
AT yuanyaling emergenceofoptramediatedlinezolidresistanceinenterococcusfaeciumamolecularinvestigationinatertiaryhospitalofsouthwestchinafrom20142018
AT yangbingxue emergenceofoptramediatedlinezolidresistanceinenterococcusfaeciumamolecularinvestigationinatertiaryhospitalofsouthwestchinafrom20142018
AT huangjinzhu emergenceofoptramediatedlinezolidresistanceinenterococcusfaeciumamolecularinvestigationinatertiaryhospitalofsouthwestchinafrom20142018
AT xiapeiwen emergenceofoptramediatedlinezolidresistanceinenterococcusfaeciumamolecularinvestigationinatertiaryhospitalofsouthwestchinafrom20142018
AT xiayun emergenceofoptramediatedlinezolidresistanceinenterococcusfaeciumamolecularinvestigationinatertiaryhospitalofsouthwestchinafrom20142018